The effectiveness of high-intensity focused ultrasound combined with curettage in the treatment of cesarean scar pregnancy and its effect on ovarian reserve

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000040357

Enrollment

Unknown

Registered

2020-11-28

Start date

2020-12-01

Completion date

Unknown

Last updated

2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caesarean scar pregnancy

Interventions

Case series:high-intensity focused ultrasound (HIFU) ablation

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 20 to 40 years old; 2. All subjects meet the CSP diagnostic criteria of the 9th edition of Obstetrics and Gynecology; 3. Stable vital signs, willing to receive HIFU treatment, and sign the HIFU treatment consent form; 4. No language barriers; 5. There is no obvious attenuation when the diagnostic ultrasound is checked through the abdomen.

Exclusion criteria

Exclusion criteria: 1. Patients with organic diseases of vital organs and unable to tolerate surgery; 2. Language communication disorders, unable to prone position; 3. Patients with lower abdominal scar width >=1 cm; 4. Patients with endocrine diseases, hypertension, coronary heart disease, obesity And those who have used steroid hormones within half a year; 5. Other situations not suitable for HIFU treatment.

Design outcomes

Primary

Measure	Time frame
serum anti-Müllerian hormone (AMH);	—

Contacts

Public ContactWang Wenping

Affiliated Hospital of North Sichuan Medical College

doctorwwp@sina.com+86 15228113675

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026